Similar articles

• Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.

  Convit J, Sampson C, Zúñiga M, Smith PG, Plata J, Silva J, Molina J, Pinardi ME, Bloom BR, Salgado A. Convit J, et al. Lancet. 1992 Feb 22;339(8791):446-50. doi: 10.1016/0140-6736(92)91056-e. Lancet. 1992. PMID: 1346818 Clinical Trial.
• South India immunoprophylaxis trial against leprosy: relevance of findings in the context of leprosy trends.

  Gupte MD. Gupte MD. Int J Lepr Other Mycobact Dis. 2001 Jun;69(2 Suppl):S10-3. Int J Lepr Other Mycobact Dis. 2001. PMID: 11757173 Clinical Trial. No abstract available.
• Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.

  Gormus BJ, Baskin GB, Xu K, Ratterree MS, Martin LN, Mack PA, Bohm RP Jr, Meyers WM, Walsh GP. Gormus BJ, et al. Int J Lepr Other Mycobact Dis. 2000 Dec;68(4):434-43. Int J Lepr Other Mycobact Dis. 2000. PMID: 11332286
• A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.

  Bretscher PA. Bretscher PA. Immunol Today. 1992 Sep;13(9):342-5. doi: 10.1016/0167-5699(92)90168-7. Immunol Today. 1992. PMID: 1466750 Review.
• Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.

  Gormus BJ, Meyers WM. Gormus BJ, et al. Expert Rev Vaccines. 2003 Dec;2(6):791-804. doi: 10.1586/14760584.2.6.791. Expert Rev Vaccines. 2003. PMID: 14711362 Review.